

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | central nervous system myelination (GO:0022010) | 5.62167142 |
| 2 | axon ensheathment in central nervous system (GO:0032291) | 5.62167142 |
| 3 | postsynaptic membrane organization (GO:0001941) | 5.21425462 |
| 4 | myelination (GO:0042552) | 4.96045679 |
| 5 | ensheathment of neurons (GO:0007272) | 4.95492740 |
| 6 | axon ensheathment (GO:0008366) | 4.95492740 |
| 7 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.81951704 |
| 8 | fatty acid elongation (GO:0030497) | 4.80484858 |
| 9 | locomotory exploration behavior (GO:0035641) | 4.51654084 |
| 10 | neuron cell-cell adhesion (GO:0007158) | 4.46800626 |
| 11 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.40106347 |
| 12 | negative regulation of neurotransmitter secretion (GO:0046929) | 4.38878937 |
| 13 | L-amino acid import (GO:0043092) | 4.31315466 |
| 14 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 4.20071176 |
| 15 | presynaptic membrane assembly (GO:0097105) | 4.18683436 |
| 16 | long-chain fatty acid biosynthetic process (GO:0042759) | 4.09280457 |
| 17 | sodium ion export (GO:0071436) | 4.06959104 |
| 18 | transmission of nerve impulse (GO:0019226) | 4.02409011 |
| 19 | cellular potassium ion homeostasis (GO:0030007) | 3.90895984 |
| 20 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.85081528 |
| 21 | negative regulation of neurotransmitter transport (GO:0051589) | 3.77577842 |
| 22 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.77379687 |
| 23 | regulation of synapse structural plasticity (GO:0051823) | 3.76779718 |
| 24 | cholesterol biosynthetic process (GO:0006695) | 3.71104531 |
| 25 | presynaptic membrane organization (GO:0097090) | 3.70471451 |
| 26 | substantia nigra development (GO:0021762) | 3.67820212 |
| 27 | amino acid import (GO:0043090) | 3.56492428 |
| 28 | synaptic vesicle maturation (GO:0016188) | 3.55601822 |
| 29 | neuronal action potential propagation (GO:0019227) | 3.55278100 |
| 30 | central nervous system projection neuron axonogenesis (GO:0021952) | 3.52485277 |
| 31 | dendrite morphogenesis (GO:0048813) | 3.49140108 |
| 32 | peripheral nervous system axon ensheathment (GO:0032292) | 3.48745242 |
| 33 | myelination in peripheral nervous system (GO:0022011) | 3.48745242 |
| 34 | auditory behavior (GO:0031223) | 3.46019835 |
| 35 | neuronal ion channel clustering (GO:0045161) | 3.45122535 |
| 36 | neuron recognition (GO:0008038) | 3.44490427 |
| 37 | negative regulation of axonogenesis (GO:0050771) | 3.41590842 |
| 38 | activated T cell proliferation (GO:0050798) | 3.41546676 |
| 39 | regulation of collateral sprouting (GO:0048670) | 3.40688788 |
| 40 | negative regulation of axon extension (GO:0030517) | 3.37825030 |
| 41 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.34865186 |
| 42 | glycerophospholipid catabolic process (GO:0046475) | 3.33960674 |
| 43 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.33950836 |
| 44 | dendritic spine morphogenesis (GO:0060997) | 3.32951444 |
| 45 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.31038107 |
| 46 | exploration behavior (GO:0035640) | 3.30361565 |
| 47 | axonal fasciculation (GO:0007413) | 3.29722377 |
| 48 | synaptic vesicle exocytosis (GO:0016079) | 3.28707066 |
| 49 | response to auditory stimulus (GO:0010996) | 3.28621428 |
| 50 | sterol biosynthetic process (GO:0016126) | 3.27865642 |
| 51 | semaphorin-plexin signaling pathway (GO:0071526) | 3.25941123 |
| 52 | neuromuscular process controlling balance (GO:0050885) | 3.25608290 |
| 53 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.25220383 |
| 54 | adhesion of symbiont to host cell (GO:0044650) | 3.24338957 |
| 55 | virion attachment to host cell (GO:0019062) | 3.24338957 |
| 56 | cerebellar granule cell differentiation (GO:0021707) | 3.24065683 |
| 57 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.24064948 |
| 58 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.23176044 |
| 59 | cerebral cortex radially oriented cell migration (GO:0021799) | 3.22891041 |
| 60 | cellular response to epinephrine stimulus (GO:0071872) | 3.21617941 |
| 61 | neurotransmitter uptake (GO:0001504) | 3.18757836 |
| 62 | nerve growth factor signaling pathway (GO:0038180) | 3.18597373 |
| 63 | cell communication by electrical coupling (GO:0010644) | 3.18567542 |
| 64 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.13587989 |
| 65 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.10909948 |
| 66 | neurotransmitter secretion (GO:0007269) | 3.07787390 |
| 67 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.07357397 |
| 68 | glutamate secretion (GO:0014047) | 3.06776582 |
| 69 | cell migration in hindbrain (GO:0021535) | 3.06521386 |
| 70 | positive regulation of dendritic spine development (GO:0060999) | 3.05201332 |
| 71 | dermatan sulfate biosynthetic process (GO:0030208) | 3.03657703 |
| 72 | membrane assembly (GO:0071709) | 3.02364059 |
| 73 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 3.01981989 |
| 74 | negative regulation of dendrite development (GO:2000171) | 3.01629968 |
| 75 | suckling behavior (GO:0001967) | 3.01278557 |
| 76 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.01144412 |
| 77 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.99850526 |
| 78 | response to redox state (GO:0051775) | 2.99179610 |
| 79 | potassium ion import (GO:0010107) | 2.98642071 |
| 80 | oligodendrocyte differentiation (GO:0048709) | 2.98435308 |
| 81 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.93804307 |
| 82 | response to epinephrine (GO:0071871) | 2.90433700 |
| 83 | mechanosensory behavior (GO:0007638) | 2.90127281 |
| 84 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.88661620 |
| 85 | regulation of neurotransmitter secretion (GO:0046928) | 2.85705734 |
| 86 | protein localization to synapse (GO:0035418) | 2.85307075 |
| 87 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.85231724 |
| 88 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.84649561 |
| 89 | synaptic vesicle endocytosis (GO:0048488) | 2.80978247 |
| 90 | glutamate receptor signaling pathway (GO:0007215) | 2.80656367 |
| 91 | startle response (GO:0001964) | 2.80290694 |
| 92 | gamma-aminobutyric acid transport (GO:0015812) | 2.80281279 |
| 93 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.79366442 |
| 94 | long-term memory (GO:0007616) | 2.79306682 |
| 95 | vocalization behavior (GO:0071625) | 2.79280683 |
| 96 | positive regulation of actin filament depolymerization (GO:0030836) | 2.78382159 |
| 97 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.77407994 |
| 98 | neuron remodeling (GO:0016322) | 2.76530671 |
| 99 | Notch signaling involved in heart development (GO:0061314) | 2.75431743 |
| 100 | import into cell (GO:0098657) | 2.74682938 |
| 101 | central nervous system neuron axonogenesis (GO:0021955) | 2.73548720 |
| 102 | adult walking behavior (GO:0007628) | 2.73471880 |
| 103 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 2.73402362 |
| 104 | response to hepatocyte growth factor (GO:0035728) | 2.73402362 |
| 105 | activation of protein kinase A activity (GO:0034199) | 2.73271717 |
| 106 | cellular sodium ion homeostasis (GO:0006883) | 2.72711901 |
| 107 | axon extension (GO:0048675) | 2.72277024 |
| 108 | layer formation in cerebral cortex (GO:0021819) | 2.70570314 |
| 109 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.70453206 |
| 110 | asymmetric protein localization (GO:0008105) | 2.69563617 |
| 111 | potassium ion homeostasis (GO:0055075) | 2.68986828 |
| 112 | nucleobase catabolic process (GO:0046113) | 2.67159603 |
| 113 | neurotransmitter transport (GO:0006836) | 2.65497698 |
| 114 | establishment of mitochondrion localization (GO:0051654) | 2.65411651 |
| 115 | cellular response to monoamine stimulus (GO:0071868) | 2.64438250 |
| 116 | cellular response to catecholamine stimulus (GO:0071870) | 2.64438250 |
| 117 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 2.64369233 |
| 118 | regulation of synaptic vesicle transport (GO:1902803) | 2.64040474 |
| 119 | establishment of nucleus localization (GO:0040023) | 2.63322868 |
| 120 | astrocyte development (GO:0014002) | 2.62591540 |
| 121 | apical protein localization (GO:0045176) | 2.62319053 |
| 122 | regulation of postsynaptic membrane potential (GO:0060078) | 2.61883594 |
| 123 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.61798890 |
| 124 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.60449054 |
| 125 | positive regulation of synapse assembly (GO:0051965) | 2.60301917 |
| 126 | dermatan sulfate metabolic process (GO:0030205) | 2.58245253 |
| 127 | positive regulation of neurological system process (GO:0031646) | 2.57582952 |
| 128 | response to methylmercury (GO:0051597) | 2.57042285 |
| 129 | neuromuscular process (GO:0050905) | 2.56871545 |
| 130 | isoprenoid biosynthetic process (GO:0008299) | 2.56622847 |
| 131 | synaptic transmission, glutamatergic (GO:0035249) | 2.56328545 |
| 132 | regulation of axon extension involved in axon guidance (GO:0048841) | 2.56172758 |
| 133 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.55792930 |
| 134 | regulation of synaptic plasticity (GO:0048167) | 2.53975940 |
| 135 | positive regulation of membrane potential (GO:0045838) | 2.52874241 |
| 136 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.52708504 |
| 137 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.51474654 |
| 138 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.50529808 |
| 139 | long-term synaptic potentiation (GO:0060291) | 2.50297240 |
| 140 | regulation of dendritic spine development (GO:0060998) | 2.48327931 |
| 141 | L-glutamate transport (GO:0015813) | 2.48292925 |
| 142 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.47335276 |
| 143 | synapse organization (GO:0050808) | 2.47321642 |
| 144 | adhesion of symbiont to host (GO:0044406) | 2.46330648 |
| 145 | neuron-neuron synaptic transmission (GO:0007270) | 2.45754988 |
| 146 | peripheral nervous system development (GO:0007422) | 2.45676807 |
| 147 | neural nucleus development (GO:0048857) | 2.44191126 |
| 148 | phosphatidylinositol 3-kinase signaling (GO:0014065) | 2.43086522 |
| 149 | acidic amino acid transport (GO:0015800) | 2.43044692 |
| 150 | eye photoreceptor cell differentiation (GO:0001754) | 2.40562849 |
| 151 | photoreceptor cell differentiation (GO:0046530) | 2.40562849 |
| 152 | response to catecholamine (GO:0071869) | 2.39540994 |
| 153 | response to monoamine (GO:0071867) | 2.39540994 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.41830044 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.94246205 |
| 3 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.76110040 |
| 4 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.66871305 |
| 5 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.66723766 |
| 6 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.29989918 |
| 7 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.29989918 |
| 8 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.28857351 |
| 9 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.26297869 |
| 10 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.26010888 |
| 11 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.25050079 |
| 12 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.21404754 |
| 13 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.19893172 |
| 14 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.16351449 |
| 15 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.15940441 |
| 16 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.15823364 |
| 17 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.09974222 |
| 18 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.06713493 |
| 19 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.05942900 |
| 20 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.01909995 |
| 21 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.92467255 |
| 22 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.92055521 |
| 23 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.90929110 |
| 24 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.89809078 |
| 25 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.89402260 |
| 26 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.83563379 |
| 27 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.81874574 |
| 28 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.80507854 |
| 29 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.77599879 |
| 30 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.74215065 |
| 31 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.71857528 |
| 32 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.71407689 |
| 33 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.69172258 |
| 34 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.66793201 |
| 35 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 1.65523211 |
| 36 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.65182770 |
| 37 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.63709573 |
| 38 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.60453947 |
| 39 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.59696000 |
| 40 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.57784857 |
| 41 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.55094205 |
| 42 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.54613485 |
| 43 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.54520111 |
| 44 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.54046718 |
| 45 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.54040521 |
| 46 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.53249540 |
| 47 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.50502829 |
| 48 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.50483015 |
| 49 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.49060746 |
| 50 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.48294897 |
| 51 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.44998638 |
| 52 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.43461884 |
| 53 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.43461884 |
| 54 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.42706402 |
| 55 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.42269073 |
| 56 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.38582061 |
| 57 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.34907652 |
| 58 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.34794126 |
| 59 | VDR_22108803_ChIP-Seq_LS180_Human | 1.33381618 |
| 60 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.32620122 |
| 61 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.32080598 |
| 62 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.31109893 |
| 63 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.30382120 |
| 64 | TP53_16413492_ChIP-PET_HCT116_Human | 1.29873147 |
| 65 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.28664680 |
| 66 | FUS_26573619_Chip-Seq_HEK293_Human | 1.28187659 |
| 67 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.27735071 |
| 68 | STAT3_23295773_ChIP-Seq_U87_Human | 1.25221200 |
| 69 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.24230389 |
| 70 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.24204790 |
| 71 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.23508510 |
| 72 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.22054573 |
| 73 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.21740767 |
| 74 | * SOX9_26525672_Chip-Seq_HEART_Mouse | 1.20335545 |
| 75 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.20083242 |
| 76 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.18728944 |
| 77 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.18471558 |
| 78 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.15838083 |
| 79 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.15314503 |
| 80 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.14405594 |
| 81 | KDM2B_26808549_Chip-Seq_REH_Human | 1.14388402 |
| 82 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.14238880 |
| 83 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.13929865 |
| 84 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.13921623 |
| 85 | * CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.13833948 |
| 86 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 1.13600227 |
| 87 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.13371159 |
| 88 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.12055497 |
| 89 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 1.10524295 |
| 90 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.09747023 |
| 91 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.08799265 |
| 92 | TCF4_23295773_ChIP-Seq_U87_Human | 1.08079943 |
| 93 | RXR_22108803_ChIP-Seq_LS180_Human | 1.07631032 |
| 94 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.07502008 |
| 95 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.06144372 |
| 96 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.06066642 |
| 97 | AR_25329375_ChIP-Seq_VCAP_Human | 1.05879660 |
| 98 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.05110104 |
| 99 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.04977483 |
| 100 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.03633332 |
| 101 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.03349753 |
| 102 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.99220761 |
| 103 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.99090482 |
| 104 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.98927678 |
| 105 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.98201085 |
| 106 | * P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.97689180 |
| 107 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.96841698 |
| 108 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.96805018 |
| 109 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.96249890 |
| 110 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96067636 |
| 111 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.94579174 |
| 112 | * AR_19668381_ChIP-Seq_PC3_Human | 0.94394276 |
| 113 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.93611590 |
| 114 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.93611590 |
| 115 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.92853189 |
| 116 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.91992449 |
| 117 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.91765893 |
| 118 | * JUN_21703547_ChIP-Seq_K562_Human | 0.90979611 |
| 119 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.90784676 |
| 120 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.90698746 |
| 121 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.90680415 |
| 122 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.90475926 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 4.80233570 |
| 2 | MP0003880_abnormal_central_pattern | 4.78205728 |
| 3 | MP0000920_abnormal_myelination | 4.08661417 |
| 4 | MP0004270_analgesia | 3.71954573 |
| 5 | MP0003690_abnormal_glial_cell | 3.39951827 |
| 6 | MP0003635_abnormal_synaptic_transmissio | 3.07011021 |
| 7 | MP0002064_seizures | 2.93197708 |
| 8 | MP0000778_abnormal_nervous_system | 2.71587441 |
| 9 | MP0009745_abnormal_behavioral_response | 2.67674200 |
| 10 | MP0003329_amyloid_beta_deposits | 2.60437473 |
| 11 | MP0001486_abnormal_startle_reflex | 2.52337264 |
| 12 | MP0009046_muscle_twitch | 2.49497641 |
| 13 | MP0004742_abnormal_vestibular_system | 2.43205664 |
| 14 | MP0002272_abnormal_nervous_system | 2.42296071 |
| 15 | MP0002063_abnormal_learning/memory/cond | 2.41357627 |
| 16 | MP0004885_abnormal_endolymph | 2.29879077 |
| 17 | MP0001440_abnormal_grooming_behavior | 2.29377095 |
| 18 | MP0005171_absent_coat_pigmentation | 2.19660657 |
| 19 | MP0002572_abnormal_emotion/affect_behav | 2.19573170 |
| 20 | MP0003634_abnormal_glial_cell | 2.17714183 |
| 21 | MP0002734_abnormal_mechanical_nocicepti | 2.16284769 |
| 22 | MP0001968_abnormal_touch/_nociception | 2.00785180 |
| 23 | MP0003890_abnormal_embryonic-extraembry | 1.85712219 |
| 24 | MP0005423_abnormal_somatic_nervous | 1.85695807 |
| 25 | MP0001905_abnormal_dopamine_level | 1.85494323 |
| 26 | MP0005623_abnormal_meninges_morphology | 1.79193128 |
| 27 | MP0000604_amyloidosis | 1.75093856 |
| 28 | MP0003632_abnormal_nervous_system | 1.67525563 |
| 29 | MP0002733_abnormal_thermal_nociception | 1.63923256 |
| 30 | MP0002067_abnormal_sensory_capabilities | 1.59863032 |
| 31 | MP0001485_abnormal_pinna_reflex | 1.58823577 |
| 32 | MP0002882_abnormal_neuron_morphology | 1.55458169 |
| 33 | MP0002736_abnormal_nociception_after | 1.53220164 |
| 34 | MP0000955_abnormal_spinal_cord | 1.51440628 |
| 35 | MP0001529_abnormal_vocalization | 1.48866768 |
| 36 | MP0001970_abnormal_pain_threshold | 1.46763220 |
| 37 | MP0009780_abnormal_chondrocyte_physiolo | 1.42612816 |
| 38 | MP0000462_abnormal_digestive_system | 1.41813408 |
| 39 | MP0004924_abnormal_behavior | 1.41812211 |
| 40 | MP0005386_behavior/neurological_phenoty | 1.41812211 |
| 41 | MP0004142_abnormal_muscle_tone | 1.41204452 |
| 42 | MP0005409_darkened_coat_color | 1.41149890 |
| 43 | MP0002229_neurodegeneration | 1.40193510 |
| 44 | MP0002066_abnormal_motor_capabilities/c | 1.39702801 |
| 45 | MP0004858_abnormal_nervous_system | 1.38705348 |
| 46 | MP0002735_abnormal_chemical_nociception | 1.37516244 |
| 47 | MP0002184_abnormal_innervation | 1.34470976 |
| 48 | MP0004134_abnormal_chest_morphology | 1.33512875 |
| 49 | MP0005187_abnormal_penis_morphology | 1.33049718 |
| 50 | MP0003631_nervous_system_phenotype | 1.32052078 |
| 51 | MP0001501_abnormal_sleep_pattern | 1.29016528 |
| 52 | MP0002090_abnormal_vision | 1.27315724 |
| 53 | MP0008569_lethality_at_weaning | 1.27210793 |
| 54 | MP0003633_abnormal_nervous_system | 1.24111739 |
| 55 | MP0005167_abnormal_blood-brain_barrier | 1.22217954 |
| 56 | MP0003122_maternal_imprinting | 1.21997351 |
| 57 | MP0004811_abnormal_neuron_physiology | 1.21814110 |
| 58 | MP0001299_abnormal_eye_distance/ | 1.20961835 |
| 59 | MP0003136_yellow_coat_color | 1.19607630 |
| 60 | MP0010234_abnormal_vibrissa_follicle | 1.16425672 |
| 61 | MP0001177_atelectasis | 1.13710875 |
| 62 | MP0002295_abnormal_pulmonary_circulatio | 1.13157950 |
| 63 | MP0002557_abnormal_social/conspecific_i | 1.12590385 |
| 64 | MP0002877_abnormal_melanocyte_morpholog | 1.10656330 |
| 65 | MP0002822_catalepsy | 1.10628429 |
| 66 | MP0003705_abnormal_hypodermis_morpholog | 1.07947417 |
| 67 | MP0002152_abnormal_brain_morphology | 1.06247254 |
| 68 | MP0003950_abnormal_plasma_membrane | 1.05284254 |
| 69 | MP0005551_abnormal_eye_electrophysiolog | 1.03473313 |
| 70 | MP0001984_abnormal_olfaction | 1.03441884 |
| 71 | MP0003787_abnormal_imprinting | 1.02645245 |
| 72 | MP0003172_abnormal_lysosome_physiology | 1.02129358 |
| 73 | MP0006276_abnormal_autonomic_nervous | 1.01692134 |
| 74 | MP0001963_abnormal_hearing_physiology | 1.01370105 |
| 75 | MP0002752_abnormal_somatic_nervous | 0.99094938 |
| 76 | MP0003119_abnormal_digestive_system | 0.98771945 |
| 77 | MP0004510_myositis | 0.98072583 |
| 78 | MP0004272_abnormal_basement_membrane | 0.95562541 |
| 79 | MP0005646_abnormal_pituitary_gland | 0.95134653 |
| 80 | MP0002909_abnormal_adrenal_gland | 0.93243031 |
| 81 | MP0005058_abnormal_lysosome_morphology | 0.91002255 |
| 82 | MP0008438_abnormal_cutaneous_collagen | 0.90848057 |
| 83 | MP0005248_abnormal_Harderian_gland | 0.90789636 |
| 84 | MP0010678_abnormal_skin_adnexa | 0.85946526 |
| 85 | MP0003938_abnormal_ear_development | 0.85560928 |
| 86 | MP0003075_altered_response_to | 0.85512809 |
| 87 | MP0005310_abnormal_salivary_gland | 0.84275071 |
| 88 | MP0002638_abnormal_pupillary_reflex | 0.83591170 |
| 89 | MP0000579_abnormal_nail_morphology | 0.81189222 |
| 90 | MP0003121_genomic_imprinting | 0.81131895 |
| 91 | MP0001879_abnormal_lymphatic_vessel | 0.81052356 |
| 92 | MP0002751_abnormal_autonomic_nervous | 0.79227258 |
| 93 | MP0003303_peritoneal_inflammation | 0.79030272 |
| 94 | MP0000516_abnormal_urinary_system | 0.78028383 |
| 95 | MP0005367_renal/urinary_system_phenotyp | 0.78028383 |
| 96 | MP0004145_abnormal_muscle_electrophysio | 0.77318439 |
| 97 | MP0008874_decreased_physiological_sensi | 0.77179564 |
| 98 | MP0005195_abnormal_posterior_eye | 0.76869815 |
| 99 | MP0000534_abnormal_ureter_morphology | 0.74875580 |
| 100 | MP0002081_perinatal_lethality | 0.74595787 |
| 101 | MP0000428_abnormal_craniofacial_morphol | 0.73084465 |
| 102 | MP0003935_abnormal_craniofacial_develop | 0.71866076 |
| 103 | MP0005388_respiratory_system_phenotype | 0.69723079 |
| 104 | MP0002133_abnormal_respiratory_system | 0.69723079 |
| 105 | MP0003937_abnormal_limbs/digits/tail_de | 0.68639243 |
| 106 | MP0002896_abnormal_bone_mineralization | 0.67496442 |
| 107 | MP0006082_CNS_inflammation | 0.65693628 |
| 108 | MP0003283_abnormal_digestive_organ | 0.65645915 |
| 109 | MP0005253_abnormal_eye_physiology | 0.65316142 |
| 110 | MP0001915_intracranial_hemorrhage | 0.64761590 |
| 111 | MP0000026_abnormal_inner_ear | 0.64171484 |
| 112 | MP0000383_abnormal_hair_follicle | 0.63596957 |
| 113 | MP0002233_abnormal_nose_morphology | 0.63179682 |
| 114 | MP0002697_abnormal_eye_size | 0.62096996 |
| 115 | MP0004215_abnormal_myocardial_fiber | 0.61855314 |
| 116 | MP0001502_abnormal_circadian_rhythm | 0.61204395 |
| 117 | MP0010769_abnormal_survival | 0.60442649 |
| 118 | MP0010770_preweaning_lethality | 0.60061256 |
| 119 | MP0000647_abnormal_sebaceous_gland | 0.59611319 |
| 120 | MP0002069_abnormal_eating/drinking_beha | 0.58000698 |
| 121 | MP0003385_abnormal_body_wall | 0.57868396 |
| 122 | MP0001943_abnormal_respiration | 0.57551980 |
| 123 | MP0003861_abnormal_nervous_system | 0.57498081 |
| 124 | MP0004185_abnormal_adipocyte_glucose | 0.57116248 |
| 125 | MP0000747_muscle_weakness | 0.55612313 |
| 126 | MP0003091_abnormal_cell_migration | 0.54791647 |
| 127 | MP0001851_eye_inflammation | 0.54787044 |
| 128 | MP0001661_extended_life_span | 0.52636776 |
| 129 | MP0000569_abnormal_digit_pigmentation | 0.51277248 |
| 130 | MP0009250_abnormal_appendicular_skeleto | 0.48005268 |
| 131 | MP0001346_abnormal_lacrimal_gland | 0.47729285 |
| 132 | MP0004130_abnormal_muscle_cell | 0.47087351 |
| 133 | MP0000537_abnormal_urethra_morphology | 0.46953840 |
| 134 | MP0005410_abnormal_fertilization | 0.46883186 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Neurofibrillary tangles (HP:0002185) | 5.79285306 |
| 2 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 5.23312959 |
| 3 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 5.23312959 |
| 4 | Sensory axonal neuropathy (HP:0003390) | 4.97020623 |
| 5 | Cerebral inclusion bodies (HP:0100314) | 4.67040023 |
| 6 | Abnormality of the corticospinal tract (HP:0002492) | 4.65451359 |
| 7 | Atonic seizures (HP:0010819) | 4.24132011 |
| 8 | Supranuclear gaze palsy (HP:0000605) | 4.20650315 |
| 9 | Akinesia (HP:0002304) | 4.16367744 |
| 10 | Insidious onset (HP:0003587) | 4.02129043 |
| 11 | Termporal pattern (HP:0011008) | 4.02129043 |
| 12 | Focal motor seizures (HP:0011153) | 3.86556809 |
| 13 | Peripheral hypomyelination (HP:0007182) | 3.64484213 |
| 14 | Myokymia (HP:0002411) | 3.63591361 |
| 15 | Focal seizures (HP:0007359) | 3.47239306 |
| 16 | Intention tremor (HP:0002080) | 3.43848664 |
| 17 | Parakeratosis (HP:0001036) | 3.37338663 |
| 18 | Action tremor (HP:0002345) | 3.36849049 |
| 19 | Dysmetria (HP:0001310) | 3.23281180 |
| 20 | Papillary thyroid carcinoma (HP:0002895) | 3.21249039 |
| 21 | Spastic gait (HP:0002064) | 3.12262692 |
| 22 | Epileptic encephalopathy (HP:0200134) | 2.87004181 |
| 23 | Onion bulb formation (HP:0003383) | 2.83022458 |
| 24 | Urinary urgency (HP:0000012) | 2.81544178 |
| 25 | Cerebral hemorrhage (HP:0001342) | 2.80639324 |
| 26 | Limb dystonia (HP:0002451) | 2.72114219 |
| 27 | Cortical dysplasia (HP:0002539) | 2.69393310 |
| 28 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.69153621 |
| 29 | Inappropriate behavior (HP:0000719) | 2.63869965 |
| 30 | Dialeptic seizures (HP:0011146) | 2.60843796 |
| 31 | Mutism (HP:0002300) | 2.56120348 |
| 32 | Hyperventilation (HP:0002883) | 2.53370052 |
| 33 | Absence seizures (HP:0002121) | 2.53019053 |
| 34 | Truncal ataxia (HP:0002078) | 2.50277973 |
| 35 | Generalized myoclonic seizures (HP:0002123) | 2.50197973 |
| 36 | Relative macrocephaly (HP:0004482) | 2.49052844 |
| 37 | Pheochromocytoma (HP:0002666) | 2.47564014 |
| 38 | Fetal akinesia sequence (HP:0001989) | 2.45364445 |
| 39 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.44574407 |
| 40 | Scanning speech (HP:0002168) | 2.43876586 |
| 41 | Clumsiness (HP:0002312) | 2.43244876 |
| 42 | Small epiphyses (HP:0010585) | 2.42961671 |
| 43 | Progressive cerebellar ataxia (HP:0002073) | 2.40004528 |
| 44 | Disinhibition (HP:0000734) | 2.38772420 |
| 45 | Hemiplegia (HP:0002301) | 2.37651070 |
| 46 | Agnosia (HP:0010524) | 2.34239694 |
| 47 | Alacrima (HP:0000522) | 2.33611329 |
| 48 | Coronal craniosynostosis (HP:0004440) | 2.29807464 |
| 49 | Abnormality of binocular vision (HP:0011514) | 2.29709064 |
| 50 | Diplopia (HP:0000651) | 2.29709064 |
| 51 | Abnormality of glycolysis (HP:0004366) | 2.28095914 |
| 52 | Increased serum pyruvate (HP:0003542) | 2.28095914 |
| 53 | Broad-based gait (HP:0002136) | 2.26777812 |
| 54 | Abnormality of the parathyroid morphology (HP:0011766) | 2.24424914 |
| 55 | Split foot (HP:0001839) | 2.22937834 |
| 56 | Megalencephaly (HP:0001355) | 2.20853973 |
| 57 | Retinal dysplasia (HP:0007973) | 2.18655459 |
| 58 | Lower limb muscle weakness (HP:0007340) | 2.16954003 |
| 59 | Apathy (HP:0000741) | 2.16150761 |
| 60 | Hemiparesis (HP:0001269) | 2.15869003 |
| 61 | Slow saccadic eye movements (HP:0000514) | 2.15806586 |
| 62 | Spastic tetraparesis (HP:0001285) | 2.15421069 |
| 63 | Ankle clonus (HP:0011448) | 2.14912740 |
| 64 | Dysdiadochokinesis (HP:0002075) | 2.13675779 |
| 65 | Thickened helices (HP:0000391) | 2.13026287 |
| 66 | Generalized tonic-clonic seizures (HP:0002069) | 2.12882656 |
| 67 | Neuroendocrine neoplasm (HP:0100634) | 2.12767736 |
| 68 | Visual hallucinations (HP:0002367) | 2.11802875 |
| 69 | Progressive inability to walk (HP:0002505) | 2.11424429 |
| 70 | Abnormal eating behavior (HP:0100738) | 2.09486340 |
| 71 | Neoplasm of the peripheral nervous system (HP:0100007) | 2.08079884 |
| 72 | Diminished movement (HP:0002374) | 2.07805661 |
| 73 | Absent speech (HP:0001344) | 2.06568820 |
| 74 | Widely spaced teeth (HP:0000687) | 2.05294387 |
| 75 | Increased cerebral lipofuscin (HP:0011813) | 2.03794487 |
| 76 | Anteriorly placed anus (HP:0001545) | 2.03645030 |
| 77 | Abnormality of the ischium (HP:0003174) | 2.03224936 |
| 78 | Steppage gait (HP:0003376) | 1.98855989 |
| 79 | Aplasia involving bones of the extremities (HP:0009825) | 1.98851572 |
| 80 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.98851572 |
| 81 | Aplasia of the phalanges of the hand (HP:0009802) | 1.98851572 |
| 82 | Gaze-evoked nystagmus (HP:0000640) | 1.98815313 |
| 83 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.98810435 |
| 84 | Protruding tongue (HP:0010808) | 1.98266258 |
| 85 | Thyroid carcinoma (HP:0002890) | 1.98254069 |
| 86 | Abnormal social behavior (HP:0012433) | 1.97727097 |
| 87 | Impaired social interactions (HP:0000735) | 1.97727097 |
| 88 | Cutaneous finger syndactyly (HP:0010554) | 1.96089459 |
| 89 | Blue irides (HP:0000635) | 1.95911533 |
| 90 | Hammertoe (HP:0001765) | 1.95560025 |
| 91 | Polyphagia (HP:0002591) | 1.94922251 |
| 92 | Pulmonic stenosis (HP:0001642) | 1.94808360 |
| 93 | Aqueductal stenosis (HP:0002410) | 1.94767823 |
| 94 | Cerebral hypomyelination (HP:0006808) | 1.93619177 |
| 95 | Abnormality of salivation (HP:0100755) | 1.93031853 |
| 96 | Insomnia (HP:0100785) | 1.92563873 |
| 97 | Lower limb asymmetry (HP:0100559) | 1.92383502 |
| 98 | Drooling (HP:0002307) | 1.92021004 |
| 99 | Excessive salivation (HP:0003781) | 1.92021004 |
| 100 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.91734290 |
| 101 | Cupped ear (HP:0000378) | 1.91194031 |
| 102 | Premature skin wrinkling (HP:0100678) | 1.90347421 |
| 103 | Arterial tortuosity (HP:0005116) | 1.89528961 |
| 104 | Partial agenesis of the corpus callosum (HP:0001338) | 1.89450639 |
| 105 | Poor eye contact (HP:0000817) | 1.88893098 |
| 106 | Thick nail (HP:0001805) | 1.88503652 |
| 107 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.87337416 |
| 108 | Cutaneous syndactyly (HP:0012725) | 1.86927744 |
| 109 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.86771374 |
| 110 | Diminished motivation (HP:0000745) | 1.86268891 |
| 111 | Febrile seizures (HP:0002373) | 1.86070108 |
| 112 | Anomalous pulmonary venous return (HP:0010772) | 1.85726757 |
| 113 | Vertebral arch anomaly (HP:0008438) | 1.85527289 |
| 114 | Abnormal auditory evoked potentials (HP:0006958) | 1.85156729 |
| 115 | Increased circulating renin level (HP:0000848) | 1.83402868 |
| 116 | Overgrowth (HP:0001548) | 1.82546569 |
| 117 | Epiphyseal dysplasia (HP:0002656) | 1.80253370 |
| 118 | Large earlobe (HP:0009748) | 1.77767554 |
| 119 | Depression (HP:0000716) | 1.77498650 |
| 120 | Ulnar claw (HP:0001178) | 1.77476150 |
| 121 | Postural instability (HP:0002172) | 1.76525770 |
| 122 | Neuronal loss in central nervous system (HP:0002529) | 1.76292804 |
| 123 | Chin dimple (HP:0010751) | 1.76176068 |
| 124 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.75681148 |
| 125 | Hypoplasia of the corpus callosum (HP:0002079) | 1.75331020 |
| 126 | Decreased lacrimation (HP:0000633) | 1.74928506 |
| 127 | Infantile muscular hypotonia (HP:0008947) | 1.74676400 |
| 128 | Bowel incontinence (HP:0002607) | 1.74205105 |
| 129 | Spastic paraparesis (HP:0002313) | 1.74179285 |
| 130 | Buphthalmos (HP:0000557) | 1.72738789 |
| 131 | Overriding aorta (HP:0002623) | 1.72670196 |
| 132 | Abnormality of the lower motor neuron (HP:0002366) | 1.71832336 |
| 133 | Postural tremor (HP:0002174) | 1.71154112 |
| 134 | Mild short stature (HP:0003502) | 1.70333977 |
| 135 | Abnormality of the vitreous humor (HP:0004327) | 1.70180948 |
| 136 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.69233862 |
| 137 | Abnormal large intestine physiology (HP:0012700) | 1.68646861 |
| 138 | Stereotypic behavior (HP:0000733) | 1.67960682 |
| 139 | Abnormality of the periventricular white matter (HP:0002518) | 1.67766070 |
| 140 | Abnormality of the pulmonary veins (HP:0011718) | 1.67702989 |
| 141 | Gait ataxia (HP:0002066) | 1.66585546 |
| 142 | Deeply set eye (HP:0000490) | 1.66247577 |
| 143 | Bladder carcinoma (HP:0002862) | 1.65539085 |
| 144 | Bladder neoplasm (HP:0009725) | 1.65539085 |
| 145 | Clonus (HP:0002169) | 1.65009182 |
| 146 | Spastic paraplegia (HP:0001258) | 1.64997459 |
| 147 | Impaired vibratory sensation (HP:0002495) | 1.64492554 |
| 148 | Ankyloglossia (HP:0010296) | 1.63820441 |
| 149 | Difficulty running (HP:0009046) | 1.63334942 |
| 150 | Vascular tortuosity (HP:0004948) | 1.62630256 |
| 151 | Arnold-Chiari malformation (HP:0002308) | 1.62424444 |
| 152 | Type II lissencephaly (HP:0007260) | 1.62313198 |
| 153 | Lower limb amyotrophy (HP:0007210) | 1.61585918 |
| 154 | Heterochromia iridis (HP:0001100) | 1.61126046 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK39 | 4.94874764 |
| 2 | TNIK | 3.84673093 |
| 3 | OXSR1 | 3.36761853 |
| 4 | EPHA4 | 2.63128435 |
| 5 | EPHB1 | 2.59381582 |
| 6 | MARK1 | 2.57117959 |
| 7 | MAP3K9 | 2.31284800 |
| 8 | TYRO3 | 2.27960405 |
| 9 | BCR | 2.23525972 |
| 10 | PAK6 | 2.03331385 |
| 11 | PKN1 | 2.00915290 |
| 12 | NTRK3 | 2.00368484 |
| 13 | WNK4 | 1.97039021 |
| 14 | NTRK1 | 1.95599650 |
| 15 | FGR | 1.88006608 |
| 16 | FES | 1.76541808 |
| 17 | CDK19 | 1.73781873 |
| 18 | UHMK1 | 1.69967848 |
| 19 | MAPK13 | 1.67424552 |
| 20 | PRPF4B | 1.66924492 |
| 21 | KSR2 | 1.59804623 |
| 22 | SGK2 | 1.56810049 |
| 23 | FGFR2 | 1.56328903 |
| 24 | PDGFRA | 1.55646326 |
| 25 | ICK | 1.55470006 |
| 26 | MINK1 | 1.53517143 |
| 27 | CASK | 1.51974867 |
| 28 | PBK | 1.37912667 |
| 29 | PNCK | 1.37749517 |
| 30 | CCNB1 | 1.34420815 |
| 31 | WNK1 | 1.32086461 |
| 32 | IRAK2 | 1.30040856 |
| 33 | MET | 1.28373626 |
| 34 | CSNK1G3 | 1.24821102 |
| 35 | CSNK1G2 | 1.24699029 |
| 36 | TSSK6 | 1.24441465 |
| 37 | PLK2 | 1.22162904 |
| 38 | CDK5 | 1.18864989 |
| 39 | SGK3 | 1.18731731 |
| 40 | RIPK4 | 1.18007840 |
| 41 | CSNK1A1L | 1.17248466 |
| 42 | MAP3K2 | 1.16508290 |
| 43 | MKNK2 | 1.16237891 |
| 44 | MAP3K4 | 1.15730300 |
| 45 | ROCK2 | 1.14162735 |
| 46 | PAK3 | 1.13473678 |
| 47 | LIMK1 | 1.13092915 |
| 48 | NTRK2 | 1.10065282 |
| 49 | YES1 | 1.09381650 |
| 50 | NEK6 | 1.08674288 |
| 51 | PRKD3 | 1.03204027 |
| 52 | ARAF | 1.02450545 |
| 53 | CDK14 | 1.02348852 |
| 54 | ERBB3 | 1.01964489 |
| 55 | DAPK2 | 0.99799085 |
| 56 | MST4 | 0.93064171 |
| 57 | MAP3K10 | 0.92744022 |
| 58 | CAMK2B | 0.91418239 |
| 59 | PTK2B | 0.89828242 |
| 60 | CSNK1G1 | 0.89740269 |
| 61 | CAMK2A | 0.89459641 |
| 62 | NEK9 | 0.86575012 |
| 63 | IRAK1 | 0.85992569 |
| 64 | GRK5 | 0.85458605 |
| 65 | MAP3K13 | 0.83797734 |
| 66 | KSR1 | 0.83372519 |
| 67 | DMPK | 0.82879160 |
| 68 | MAP2K7 | 0.80283367 |
| 69 | FYN | 0.79933692 |
| 70 | CAMK2D | 0.79845529 |
| 71 | CDK15 | 0.79633224 |
| 72 | WNK3 | 0.79261679 |
| 73 | MKNK1 | 0.78926166 |
| 74 | PRKCQ | 0.78300892 |
| 75 | MAP2K4 | 0.78255445 |
| 76 | CDK18 | 0.77673816 |
| 77 | PDGFRB | 0.70662731 |
| 78 | RET | 0.70326735 |
| 79 | TAF1 | 0.70058380 |
| 80 | ERBB4 | 0.69424452 |
| 81 | PRKCE | 0.68004076 |
| 82 | SGK494 | 0.67491026 |
| 83 | SGK223 | 0.67491026 |
| 84 | CDK11A | 0.67140642 |
| 85 | PDPK1 | 0.66876202 |
| 86 | ROCK1 | 0.65508822 |
| 87 | CAMKK1 | 0.63947739 |
| 88 | STK38L | 0.61887142 |
| 89 | MAPK10 | 0.61475752 |
| 90 | MARK2 | 0.61048247 |
| 91 | DYRK2 | 0.60938125 |
| 92 | CAMK1D | 0.60827989 |
| 93 | STK11 | 0.60773721 |
| 94 | DYRK1A | 0.60139380 |
| 95 | ABL2 | 0.59539541 |
| 96 | PHKG2 | 0.59400795 |
| 97 | PHKG1 | 0.59400795 |
| 98 | ALK | 0.58793515 |
| 99 | PRKCG | 0.57356177 |
| 100 | RAF1 | 0.57204228 |
| 101 | CAMK1G | 0.56292816 |
| 102 | CLK1 | 0.55588275 |
| 103 | PLK3 | 0.54562232 |
| 104 | BRD4 | 0.54412918 |
| 105 | BRAF | 0.54372541 |
| 106 | STK24 | 0.53886806 |
| 107 | MAPKAPK5 | 0.53696030 |
| 108 | PINK1 | 0.53541901 |
| 109 | IRAK4 | 0.52763854 |
| 110 | TIE1 | 0.52687462 |
| 111 | WEE1 | 0.52185284 |
| 112 | MAPK12 | 0.52043333 |
| 113 | CAMKK2 | 0.50985596 |
| 114 | CSK | 0.50397035 |
| 115 | PTK2 | 0.46783591 |
| 116 | CDK3 | 0.45903469 |
| 117 | CAMK2G | 0.45625635 |
| 118 | PRKCH | 0.45590369 |
| 119 | PDK1 | 0.44794331 |
| 120 | BMX | 0.43039122 |
| 121 | BMPR2 | 0.42292465 |
| 122 | SIK2 | 0.40882195 |
| 123 | SGK1 | 0.40830411 |
| 124 | CAMK1 | 0.40126527 |
| 125 | RIPK1 | 0.39797995 |
| 126 | CAMK4 | 0.39399976 |
| 127 | LATS2 | 0.38673199 |
| 128 | DDR2 | 0.38306161 |
| 129 | PRKG1 | 0.37996665 |
| 130 | EPHB2 | 0.37889229 |
| 131 | ACVR1B | 0.37767954 |
| 132 | MOS | 0.37217598 |
| 133 | INSR | 0.37025574 |
| 134 | MAP3K12 | 0.36885388 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 3.63733839 |
| 2 | Steroid biosynthesis_Homo sapiens_hsa00100 | 3.17572224 |
| 3 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.78231527 |
| 4 | Axon guidance_Homo sapiens_hsa04360 | 2.31025358 |
| 5 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.11474434 |
| 6 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.04084374 |
| 7 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.93501185 |
| 8 | Nicotine addiction_Homo sapiens_hsa05033 | 1.89326169 |
| 9 | GABAergic synapse_Homo sapiens_hsa04727 | 1.85822511 |
| 10 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.82611298 |
| 11 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.78297515 |
| 12 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.77561455 |
| 13 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.71180971 |
| 14 | Long-term depression_Homo sapiens_hsa04730 | 1.70062812 |
| 15 | Morphine addiction_Homo sapiens_hsa05032 | 1.62009446 |
| 16 | Long-term potentiation_Homo sapiens_hsa04720 | 1.62000800 |
| 17 | Circadian entrainment_Homo sapiens_hsa04713 | 1.60789488 |
| 18 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.57536241 |
| 19 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.50878689 |
| 20 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.46453022 |
| 21 | Salivary secretion_Homo sapiens_hsa04970 | 1.44380417 |
| 22 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.43994650 |
| 23 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.39203536 |
| 24 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.35836814 |
| 25 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.26904421 |
| 26 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.25779852 |
| 27 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.21412735 |
| 28 | Renin secretion_Homo sapiens_hsa04924 | 1.21065299 |
| 29 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.17805806 |
| 30 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.17549855 |
| 31 | Endometrial cancer_Homo sapiens_hsa05213 | 1.16871541 |
| 32 | Olfactory transduction_Homo sapiens_hsa04740 | 1.14449301 |
| 33 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.12734500 |
| 34 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.08705424 |
| 35 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.05666556 |
| 36 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.05501073 |
| 37 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 1.04771424 |
| 38 | Colorectal cancer_Homo sapiens_hsa05210 | 1.03748600 |
| 39 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.03367346 |
| 40 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.03075359 |
| 41 | Gap junction_Homo sapiens_hsa04540 | 1.03072630 |
| 42 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.02588633 |
| 43 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.01932480 |
| 44 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.00295571 |
| 45 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.00095741 |
| 46 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.98420209 |
| 47 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.98131279 |
| 48 | Adherens junction_Homo sapiens_hsa04520 | 0.96322357 |
| 49 | Phagosome_Homo sapiens_hsa04145 | 0.95309839 |
| 50 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.94881295 |
| 51 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.92658019 |
| 52 | Endocytosis_Homo sapiens_hsa04144 | 0.91124114 |
| 53 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.90587597 |
| 54 | Alzheimers disease_Homo sapiens_hsa05010 | 0.90509093 |
| 55 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.89382284 |
| 56 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.89010597 |
| 57 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.88575026 |
| 58 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.88328506 |
| 59 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.88133012 |
| 60 | Glioma_Homo sapiens_hsa05214 | 0.87629780 |
| 61 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.87617942 |
| 62 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.87494648 |
| 63 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.87369191 |
| 64 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.86466199 |
| 65 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.82560856 |
| 66 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.82235605 |
| 67 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.81056416 |
| 68 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.81030320 |
| 69 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.80931744 |
| 70 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.80308638 |
| 71 | Cocaine addiction_Homo sapiens_hsa05030 | 0.79199124 |
| 72 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.78384827 |
| 73 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.78270840 |
| 74 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.77836809 |
| 75 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.77032409 |
| 76 | Prion diseases_Homo sapiens_hsa05020 | 0.75722473 |
| 77 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.75667286 |
| 78 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.75001629 |
| 79 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.73642031 |
| 80 | Alcoholism_Homo sapiens_hsa05034 | 0.70342418 |
| 81 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.69211582 |
| 82 | Salmonella infection_Homo sapiens_hsa05132 | 0.69125837 |
| 83 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.68768837 |
| 84 | Tight junction_Homo sapiens_hsa04530 | 0.67843637 |
| 85 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.67831212 |
| 86 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.67611398 |
| 87 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.67111915 |
| 88 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.66416583 |
| 89 | Lysosome_Homo sapiens_hsa04142 | 0.66029895 |
| 90 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.65498753 |
| 91 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.65433353 |
| 92 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.65304144 |
| 93 | Taste transduction_Homo sapiens_hsa04742 | 0.65296287 |
| 94 | Circadian rhythm_Homo sapiens_hsa04710 | 0.64832963 |
| 95 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.64438454 |
| 96 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.63509228 |
| 97 | Insulin secretion_Homo sapiens_hsa04911 | 0.63362727 |
| 98 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.63353937 |
| 99 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.63131080 |
| 100 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.62036339 |
| 101 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.61719160 |
| 102 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.61060580 |
| 103 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.60154726 |
| 104 | Melanogenesis_Homo sapiens_hsa04916 | 0.59965868 |
| 105 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.59908833 |
| 106 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.59161201 |
| 107 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.58980500 |
| 108 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.58395732 |
| 109 | Bile secretion_Homo sapiens_hsa04976 | 0.57033568 |
| 110 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.56795762 |
| 111 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.55756445 |
| 112 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.55754253 |
| 113 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.54909789 |
| 114 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.54530798 |
| 115 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.54201128 |
| 116 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.54070777 |
| 117 | Focal adhesion_Homo sapiens_hsa04510 | 0.52913211 |
| 118 | Platelet activation_Homo sapiens_hsa04611 | 0.52042635 |
| 119 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.50943575 |
| 120 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.47996053 |
| 121 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.47946884 |
| 122 | Shigellosis_Homo sapiens_hsa05131 | 0.47257744 |
| 123 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.46964780 |
| 124 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.45568277 |
| 125 | Malaria_Homo sapiens_hsa05144 | 0.43469305 |
| 126 | Amoebiasis_Homo sapiens_hsa05146 | 0.42079237 |
| 127 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.41384368 |
| 128 | Parkinsons disease_Homo sapiens_hsa05012 | 0.40770643 |
| 129 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.39145364 |
| 130 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.39130406 |
| 131 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.38846317 |
| 132 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.35653248 |
| 133 | Phototransduction_Homo sapiens_hsa04744 | 0.34600710 |
| 134 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.34304613 |

